Jerusalem, Israel

Intec Pharma Ltd.


USPTO Granted Patents = 12

% Expired Patents = 91.7



Forward Citations = 182

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Elena Kluev (7 out of 7 patents)

silverMedal Nadav Navon (7 out of 7 patents)

bronzeMedal David Kirmayer (7 out of 8 patents)

4.  Giora Carni (7 out of 7 patents)

5.  Moshe Tsabari (5 out of 5 patents)

6.  Avner Balshey (5 out of 5 patents)

7.  Erez Yofe (5 out of 5 patents)

8.  Eytan Moor (5 out of 5 patents)

9.  Michael M Friedman (4 out of 39 patents)

10.  Julia Shvetz (2 out of 2 patents)

11.  Eva Abramov (2 out of 2 patents)

12.  Zeev Weiss (2 out of 2 patents)

13.  Suher Masri (1 out of 1 patent)


12 patents:

Company Overview
Intec Pharma Ltd. is a biopharmaceutical company based in Jerusalem, Israel, focused on developing innovative drug delivery systems. The company specializes in its proprietary Accordion Pill technology, which aims to enhance the therapeutic efficacy and safety of existing medications. Intec Pharma is dedicated to addressing unmet medical needs through its research in various therapeutic areas, including central nervous system disorders and gastrointestinal diseases, leveraging advanced formulation techniques to improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#21 in Jerusalem

#521 in Israel

#48,163 in the World

Jerusalem, IL
Jerusalem, Israel
Forward Citations = 182

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intec Pharma Ltd.. Retrieved from https://idiyas.com/company/intec-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…